ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 180 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $712,500 | -14.4% | 94,496 | +12.3% | 0.02% | -14.8% |
| Q3 2022 | $832,000 | -8.5% | 84,143 | -6.4% | 0.03% | +3.8% |
| Q2 2022 | $909,000 | +8.2% | 89,895 | +4.4% | 0.03% | +52.9% |
| Q1 2022 | $840,000 | -31.1% | 86,123 | +1.2% | 0.02% | -29.2% |
| Q4 2021 | $1,220,000 | -38.4% | 85,105 | -16.4% | 0.02% | -35.1% |
| Q3 2021 | $1,979,000 | +16.3% | 101,764 | +27.2% | 0.04% | +32.1% |
| Q2 2021 | $1,702,000 | -12.2% | 79,972 | +10.1% | 0.03% | -17.6% |
| Q1 2021 | $1,938,000 | – | 72,624 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |